VZ
50
3
HCP
66
8
YUM
47
3
BWA
48
2
EXC
53
-3
LYB
39
2
EBAY
47
4
DVN
21
3
AIV
72
2
ORLY
62
2
WM
79
3
NDAQ
62
2
NRG
49
-3
HRB
57
5
DNB
82
4
GOOG
50
-3
PNC
64
4
AMG
54
2
CSCO
67
4
ADBE
49
3
VZ
50
3
HCP
66
8
YUM
47
3
BWA
48
2
EXC
53
-3
LYB
39
2
EBAY
47
4
DVN
21
3
AIV
72
2
ORLY
62
2
WM
79
3
NDAQ
62
2
NRG
49
-3
HRB
57
5
DNB
82
4
GOOG
50
-3
PNC
64
4
AMG
54
2
CSCO
67
4
ADBE
49
3
Financhill
Back

Repligen Vs. Perspective Therapeutics Industry Stock Comparison

Sell
48

RGEN
Repligen

Last Price:
142.62
Seasonality Move:
11.98%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
48
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $142.58. The Score for RGEN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $142.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGEN is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 52.98 Buy
Chaikin Money Flow: -74371 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (132.42 - 145.96) Buy
Bollinger Bands (100): (130.96 - 153.72) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 136.59 Buy
20-day SMA: 138.91 Buy
50-day SMA: 140.22 Buy
200-day SMA: 156.02 Sell
8-day EMA: 138.09 Buy
20-day EMA: 138.77 Buy
50-day EMA: 140.58 Buy
200-day EMA: 150.51 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):